Settlement
The Scripps Research Institute to Pay $10 Million to Settle False Claims Act Allegations Related to Mischarging NIH-Sponsored Research Grants
Scripps Research
PR-M09-20-25-1282Sep 22, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028Mar 19, 2020
Legal Settlement
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Mylan
PR-M09-19-NI-060Sep 30, 2019
Movement in Cases Against Pharma Regarding the Opioid Crisis
Nice Insight
PA2120Sep 11, 2019
Novartis Stands Behind Zolgensma® (onasemnogene abeparvovec-xioi) for the Treatment of Children Less than 2 Years of Age with Spinal Muscular Atrophy
Novartis
PR-M08-19-NI-023Aug 08, 2019
Opioids
Analysis of Government Data Reveals Main Players in Opioid Market
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-013Aug 07, 2019
Legal
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Nice Insight
PR-M08-19-NI-007Aug 02, 2019
Opioid Crisis
J&J Awaits Judge’s Decision in Lawsuit Filed by Oklahoma Over the Opioid Crisis
Nice Insight
PAO-M07-19-NI-021Jul 22, 2019
Announcement
Bayer Supervisory Board Takes Action to Address the Glyphosate Litigation and Welcomes the Appointment of Ken Feinberg as Mediator
Bayer
PR-M07-19-NI-009Jul 05, 2019
Advertising
Drug Companies Fight Back on TV Ad Pricing
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M06-19-NI-019Jun 21, 2019
Drug Pricing
Drug Affordability Review Board Created in Maryland
Nice Insight
PAO-M06-19-NI-007Jun 13, 2019
Opioid Crisis
Oklahoma vs. Johnson & Johnson Opioid Crisis Trial
Nice Insight
PAO-M06-19-NI-006Jun 13, 2019
Generics
State Lawsuit Charges Generic Makers with Price Fixing
Nice Insight
PAO-M05-19-NI-032May 29, 2019
Legal
AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
AbbVie
PR-M05-19-NI-056May 20, 2019
Legal
U.S. Court of Appeals Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
Eli Lilly and Company
PR-M04-19-NI-089Apr 30, 2019
Legal
Novartis Goes to Court Over Gilenya Generics
Nice Insight
PAO-M07-18-NI-020Jul 24, 2018